(b)(4).Concomitant medical products: w/hook needle (lot# sfl00436); ugykp uretexto2 uretex sup pp transobtur2kit(lot# zga00163).This event was previously reported to the fda on an alternative summary report (asr approval #: e2013038) which is no longer in effect.Because of additionally received complaint information, this and all further updates will be submitted through the 3500a form.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of pelvic prolapse and stress incontinence.It was reported that after implant, the patient experienced recurrent stress urinary incontinence, cystocele (prolapse), mesh extrusion, pain, erosion, infection, unspecified urinary problems, dyspareunia, acute cystitis, hematuria, atrophic vaginitis, exposure of vaginal mesh into vagina, incontinence of feces, sexual dysfunction, recurrent uti's, urinary frequency, and vaginal bleeding.Post-operative patient treatment included additional surgical interventions.
|